Tekla Life Sciences Investors (HQL)
$17.26-4.11%Close
SELLBEAR · day 26
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $525M
- Beta
- 0.73
- Div yield
- 12.98%
- P/E (TTM)
- 2.56
- Short % float
- 0.41%
- Days to cover
- 1.0
- SI change
- +67.3%
- 1W
- -1.71%
- 1M
- -13.09%
- vs SPY 1W
- -1.57%
- vs SPY 1M
- -15.60%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on HQL?
- LOPJLB’s latest quantitative signal on Tekla Life Sciences Investors (HQL) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is HQL in?
- Tekla Life Sciences Investors (HQL) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Tekla Life Sciences Investors (HQL) do?
- Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a …